http://pgi.re.kr/index.php?action=history&feed=atom&title=Antitope
Antitope - Revision history
2026-04-11T00:29:06Z
Revision history for this page on the wiki
MediaWiki 1.31.3
http://pgi.re.kr/index.php?title=Antitope&diff=2707&oldid=prev
WikiSysop at 12:44, 29 July 2009
2009-07-29T12:44:07Z
<p></p>
<table class="diff diff-contentalign-left" data-mw="interface">
<col class="diff-marker" />
<col class="diff-content" />
<col class="diff-marker" />
<col class="diff-content" />
<tr class="diff-title" lang="en">
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">← Older revision</td>
<td colspan="2" style="background-color: #fff; color: #222; text-align: center;">Revision as of 12:44, 29 July 2009</td>
</tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l5" >Line 5:</td>
<td colspan="2" class="diff-lineno">Line 5:</td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><p>Our main proprietary technologies are: </p></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><p>Our main proprietary technologies are: </p></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><ul></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><ul></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>     <li><a href="index.php?option=com_content&amp;task=view&amp;id=65&amp;Itemid=107"><font color="#0066cc">EpiScreen&trade;</font></a>, an <em>ex-vivo</em> immunological&nbsp;technology with multiple applications including measurment of the immunogenicity&nbsp;potential of biologics or in the determination of the immunotoxicity of NCEs</li></div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>     <li><a href="index.php?option=com_content&amp;task=view&amp;id=65&amp;Itemid=107"><font color="#0066cc">EpiScreen&trade;</font></a>, an <em>ex-vivo</em> immunological&nbsp;technology with multiple applications including measurment of the immunogenicity&nbsp;potential of biologics or in the determination of the immunotoxicity of NCEs </li></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>     <li><a href="index.php?option=com_content&amp;task=view&amp;id=63&amp;Itemid=104"><font color="#0066cc">Composite Human Antibodies&trade;</font></a>, a novel technology for the generation of non-immunogenic, humanized antibodies with the avoidance of T cell epitopes</li></div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>     <li><a href="index.php?option=com_content&amp;task=view&amp;id=63&amp;Itemid=104"><font color="#0066cc">Composite Human Antibodies&trade;</font></a>, a novel technology for the generation of non-immunogenic, humanized antibodies with the avoidance of T cell epitopes </li></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div>     <li><a href="index.php?option=com_content&amp;task=view&amp;id=64&amp;Itemid=105"><font color="#0066cc">Composite Proteins&trade;</font></a>, a technology platform for the generation of non-immunogenic therapeutic proteins.</li></div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div>     <li><a href="index.php?option=com_content&amp;task=view&amp;id=64&amp;Itemid=105"><font color="#0066cc">Composite Proteins&trade;</font></a>, a technology platform for the generation of non-immunogenic therapeutic proteins. </li></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div></ul></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div></ul></div></td></tr>
<tr><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><span class="article_seperator">&nbsp;</span>&nbsp;<a href="http://www.antitope.co.uk">http://www.antitope.co.uk</a><br /></div></td><td class='diff-marker'> </td><td style="background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div><span class="article_seperator">&nbsp;</span>&nbsp;<a href="http://www.antitope.co.uk">http://www.antitope.co.uk</a><br /></div></td></tr>
<tr><td class='diff-marker'>−</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;"><div><!-- BEGIN: CONTENT SPOTLIGHT --><!-- END: CONTENT SPOTLIGHT --></div></td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><!-- BEGIN: CONTENT SPOTLIGHT --><ins class="diffchange diffchange-inline"><br /></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline"><strong>Antitope Ltd</strong> <br /></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">Babraham Research Campus <br /></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">Babraham <br /></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">Cambridge CB22 3AT <br /></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">United Kingdom</ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline"><p>Telephone: +44(0) 1223 496190<br /></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">Fax: +44(0) 1223 496191 <br /></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline">E-mail: <a href="mailto:info@antitope.co.uk"><font color="#0066cc">info@antitope.co.uk</font></a>&nbsp;<br /></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins class="diffchange diffchange-inline"><br /></ins></div></td></tr>
<tr><td colspan="2"> </td><td class='diff-marker'>+</td><td style="color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><!-- END: CONTENT SPOTLIGHT --<ins class="diffchange diffchange-inline">></p</ins>></div></td></tr>
<!-- diff cache key pgi_re_kr:diff::1.12:old-2706:rev-2707 -->
</table>
WikiSysop
http://pgi.re.kr/index.php?title=Antitope&diff=2706&oldid=prev
WikiSysop at 12:43, 29 July 2009
2009-07-29T12:43:12Z
<p></p>
<p><b>New page</b></p><div><p>Antitope is a privately held biotechnology company focused on services to the pharmaceutical and biotechnology industry.&nbsp;<br /><br />
<br /><br />
The Company was formed in [[Cambridge]], England in 2004 in order to advance previous work of its founders in the areas of immunogenicity testing, antibody humanization and protein engineering, for the purpose of reducing immunogenicity, particularly with therapeutic monoclonal antibodies. The company also has dedicated facilities for the generation of manufacturing cell lines. Antitope has achieved rapid validation of its new technologies and has already formed important partnerships with biotechnology and pharmaceutical companies. </p><br />
<p>Our services are tailored for each study to ensure project objectives are met or exceeded.&nbsp; The Company's&nbsp;research is performed under Good Laboratory Practice (GLP) conditions and we provide ongoing discussion and detailed reports to our clients.&nbsp; Experienced project teams are assigned to each study focusing on progressing projects through to results in the minimum amount of time.&nbsp; Our clients uniformly judge us as professional and attentive partners who deliver quality results in a timely manner. </p><br />
<p>Our main proprietary technologies are: </p><br />
<ul><br />
<li><a href="index.php?option=com_content&amp;task=view&amp;id=65&amp;Itemid=107"><font color="#0066cc">EpiScreen&trade;</font></a>, an <em>ex-vivo</em> immunological&nbsp;technology with multiple applications including measurment of the immunogenicity&nbsp;potential of biologics or in the determination of the immunotoxicity of NCEs</li><br />
<li><a href="index.php?option=com_content&amp;task=view&amp;id=63&amp;Itemid=104"><font color="#0066cc">Composite Human Antibodies&trade;</font></a>, a novel technology for the generation of non-immunogenic, humanized antibodies with the avoidance of T cell epitopes</li><br />
<li><a href="index.php?option=com_content&amp;task=view&amp;id=64&amp;Itemid=105"><font color="#0066cc">Composite Proteins&trade;</font></a>, a technology platform for the generation of non-immunogenic therapeutic proteins.</li><br />
</ul><br />
<span class="article_seperator">&nbsp;</span>&nbsp;<a href="http://www.antitope.co.uk">http://www.antitope.co.uk</a><br /><br />
<!-- BEGIN: CONTENT SPOTLIGHT --><!-- END: CONTENT SPOTLIGHT --></div>
WikiSysop